Verition Fund Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,998
| Closed | -$3.38M | – | 2887 |
|
|
2025
Q1 | $3.38M | Buy |
28,998
+23,650
| +442% | +$2.76M | 0.02% | 950 |
|
|
2024
Q4 | $452K | Buy |
+5,348
| New | +$452K | ﹤0.01% | 1941 |
|
|
2023
Q2 | – | Sell |
-9,316
| Closed | -$575K | – | 1923 |
|
|
2023
Q1 | $575K | Buy |
+9,316
| New | +$575K | 0.01% | 1065 |
|
|
2022
Q4 | – | Sell |
-10,943
| Closed | -$488K | – | 1715 |
|
|
2022
Q3 | $488K | Buy |
+10,943
| New | +$488K | 0.01% | 1501 |
|
|
2020
Q2 | – | Sell |
-33,200
| Closed | -$1.95M | – | 975 |
|
|
2020
Q1 | $1.95M | Buy |
+33,200
| New | +$1.95M | 0.08% | 125 |
|